Skip to contentB
Biolargo, Inc.
B
BLGOBiolargo, Inc. Q1 2019 · 10-Q
Revenue$364.00K$364.00K±0.0% vs Q1 2018 Net Income-$2.75M-$2.75MN/M vs Q1 2018 EPS Diluted-$0.02-$0.02N/M vs Q1 2018 Gross Profit$172,000+72.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
Operating Cash Flow-$869,000N/M Margins · derivedGross margin47.3%+19.8 pt vs Q1 2018
Operating margin-456.6%−16.5 pt vs Q1 2018
Net margin-755.2%−87.6 pt vs Q1 2018
ended Mar 31, 2019 · filed May 15, 2019 · 45 d after period end